SILO Pharma Inc Ordinary Shares SILO 深 沪
等待开盘 08-27 09:30:00 美东时间
0.6519
+0.012
+1.84%
华盛通- 最 高0.6625
- 今 开0.6499
- 成交量 5.49万股
- 最 低 0.632
- 昨 收 0.6401
- 总市值 469.88万
- 52周最高 3.3699
- 市盈率 静 --
- 换手率 0.76%
- 52周最低 0.4101
- 委 比 -96.91%
- 总股本 720.78万
- 历史最高 7.26
- 量 比 0.10
- 振 幅 4.76%
- 历史最低 0.4101
- 每 手 1
- 风险率 0.38%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Silo Pharma’s Alzheimer’s Candidate SPC-14 Featured in Leading Scientific Peer-reviewed Journal
Silo Pharma announced the publication of preclinical research on its Alzheimer’s disease therapeutic, SPC-14, in the journal Alzheimer’s Research & Therapy. The study showed that SPC-14, a novel intranasal formulation combining (R,S)-ketamine with prucalopride, improved cognitive decline in a mouse model of Alzheimer’s disease. The drug targets NMDARs and 5-HT4Rs to address cognitive and neuropsychiatric symptoms. With a projected market of $30.8...
08-21 18:00
Silo Pharma’s PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway
Silo Pharma announced positive results for its 7-day large animal safety study of SPC-15, confirming the intranasal spray formulation meets FDA safety standards for clinical trials. SPC-15 demonstrated local and systemic safety with no toxicities, and its systemic exposure is comparable to oral administration. The company plans to pursue a 505(b)(2) regulatory pathway, leveraging existing data to streamline FDA approval. SPC-15 targets PTSD and s...
08-19 12:05
Silo Pharma Launches Cryptocurrency Advisory Board
An update from Silo Pharma ( ($SILO) ) is now available. On August 4, 2025, Sil...
08-06 04:55
Silo Pharma Appoints Crypto Infrastructure Pioneer Corwin Yu to Launch Institutional Bitcoin, Ethereum and Solana Treasury Platform
Silo Pharma has launched a cryptocurrency treasury strategy focusing on Bitcoin, Ethereum, and Solana, with plans to leverage staking for yield generation. The company appointed Corwin Yu, a digital asset tech pioneer, to lead this initiative and has acquired AI-powered market intelligence technology to enhance decision-making. Silo remains committed to its core biopharmaceutical business, including its PTSD drug SPC-15, which is nearing its FDA ...
08-05 12:32
Silo Pharma Acquires Digital Assets from MAVS Holdings
Silo Pharma ( ($SILO) ) has issued an announcement. On July 29, 2025, Silo Phar...
07-30 05:04
Silo Pharma Completes Dosing In FDA-Requested 7-Day Safety And Toxicology Large Animal Study Of SPC-15
Silo Pharma, Inc. (NASDAQ:SILO) ("Silo" or the "Company"), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced completion of dosing in a U.S. Food and
07-16 20:48
Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15
Silo Pharma Inc. has completed dosing in a 7-day safety and toxicology study of its PTSD drug candidate, SPC-15, with results expected in 60 days. CEO Eric Weisblum expressed confidence in the final data and noted plans to submit an investigational new drug (IND) application. Remaining studies include a GLP-compliant toxicology study and a device study of SPC-15's nasal spray system. SPC-15, an intranasal serotonin 5-HT4 receptor agonist, is bein...
07-16 12:45
Silo Pharma Secures Exclusive License for CNS Peptides
Silo Pharma ( ($SILO) ) has shared an announcement. On July 8, 2025, Silo Pharm...
07-11 05:01
Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025
Silo Pharma expects to submit an IND application for its lead asset SPC-15 targeting PTSD by late 2025, pending positive preclinical data. If approved, a Phase 1 clinical trial could begin by end of 2026. SPC-15, an intranasal 5-HT4 receptor agonist, aims to increase stress resilience and address the unmet need for PTSD treatments, with no new approvals in the U.S. in nearly 25 years. The company collaborates with Columbia University and plans to...
07-07 12:15
Silo Pharma Faces Nasdaq Non-Compliance Notice
Silo Pharma ( ($SILO) ) has provided an announcement. On June 27, 2025, Silo Ph...
07-04 05:20
